Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
69 Total results for product and free and sample content found
Pharmaprojects
By Ian Lloyd 10 Apr 2018
You’ve already tuned into Pharma R&D Annual Review 2018, the free, music-themed whitepaper from Citeline’s Pharmaprojects. Now, get even more free market data and insights with your download of Pharma R&D Annual Review 2018 Supplement: New Active Substances Launched During 2017.
Biomedtracker
05 Apr 2018
Don't miss out on this comprehensive review of all the presentations from the conference, complied by our analysts, with key points and expert insight, for you to download, for free. A full list of events and catalysts that were announced or updated during the conference is included in this report.
Topic Strategy
Pharmaprojects, Citeline
By Ian Lloyd 05 Apr 2018
Authored for the last 25 years by Ian Lloyd, Senior Director of Pharmaprojects and Data Integration, this vital resource uses a music motif to turn up the volume on the evolution of trends in pharmaceutical R&D. Lloyd assesses industry trends by examining the pipeline by company, therapeutic area, disease, target, and drug type.
Topic Research
Pharmaprojects
By Hannah Sally 29 Mar 2018
Since the discovery of the microbiome, biomedical research has been highly focused on understanding how exactly its interactions within the body contribute to health and disease, and drug development companies are very interested in understanding the potential of microbiome modulating therapies.
Topic Microbiome
Pharmaprojects
By Ian Lloyd 21 Mar 2018
Following on from our review of trends in the current pharmaceutical R&D pipeline, published in March 2017, this supplement takes a look at the industry’s success stories of 2016 – the drugs which were launched on to the market for the first time during the year.
Citeline, Trialtrove
By Laura Runkel 21 Feb 2018
Explore the current and future outlook for rheumatoid arthritis (RA) treatments. Such treatments remain ineffective for the 33% of RA sufferers who are or become unresponsive to treatment, resulting in a high interest in RA drug development to address this unmet need in the marketplace.
Trialtrove
05 Jan 2018
Sepsis is a life-threatening illness culminating in multi-organ dysfunction paired with a systemic inflammatory response. The disease burden is considerable: it is the single most expensive condition treated in hospitals, with annual costs in the US projected at nearly $24bn.
Trialtrove, Chinatrove
By Heidi Chen 30 Nov 2017
Over the last decade, it is undeniable that China has emerged as a rising star in pharmaceutical R&D
Topic Clinical trials
Chinatrove, Sitetrove
By Christina DeRuzza 24 Nov 2017
China’s 13th five-year plan 2016–20 will move the country into the center of the international stage of drug development, where they will be global innovators in the industry and more competitive than ever with foreign firms.
Topic Clinical trials Drug review
No Records Found
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Report store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
